The White House Quit Fighting the NIH Overhead Cap. The War on Public Science Just Changed Tactics.

The newsroom lights are flickering like they know something. My coffee tastes like burnt toner. Outside, the city hums with sirens and budget math, the kind that never comes for stock buybacks but always finds time to bully a lab manager trying to keep freezers cold.

Here is what changed. The Trump administration stopped fighting in court to defend the NIH’s attempt to impose a flat 15% cap on “indirect costs” for research grants. Chemical & Engineering News reported on April 10, 2026 that the government let the Supreme Court window pass after the First Circuit upheld a ruling blocking the policy earlier this year.

You can hear the PR fog machine warming up: See? We are reasonable. We are moving on. Nothing to see here.

Yeah. Sure. And subpoenas are just aggressive stationery.

What happened in court (and what that actually means)

NIH announced a 15% cap on indirect cost reimbursements in February 2025, replacing the old system of negotiated, institution-by-institution rates that often run higher. The First Circuit upheld a district court ruling blocking that cap and pointed to a recurring appropriations rider that restricts NIH from unilaterally changing how indirect costs are reimbursed. This month, the administration simply did not pursue Supreme Court review.

It was not just NIH. C&EN also reported the administration voluntarily dismissed its appeal in the Department of Energy indirect-cost fight, and AAU’s update says the First Circuit granted the government’s motion to dismiss that DOE appeal, leaving the judgment against DOE’s 15% policy permanent.

Translation: they swung a meat cleaver at the plumbing that keeps public research running, got told “no” by the courts, and decided to stop burning legal fees on a losing argument. That is not reform. That is a tactical retreat.

Translation: “Indirect costs” are not a scam

Translation: “Indirect costs” are the building, the lights, the compliance staff, the grant accountants, cybersecurity, hazardous waste disposal, and shared equipment that makes multiple projects possible. When politicians sneer about “overhead,” they are laundering a story: universities are grifters, scientists are scammers, so the public should accept austerity.

Here is the mechanism: lose in court, win in procurement

If you cannot legally impose a universal cap through agency guidance, you can still choke research by changing incentives around awards: preferences, slow-walking, scoring systems, extra hoops, selective audits, and “efficiency” initiatives that reliably land on universities and inconvenient science.

C&EN notes the administration can keep pushing constraints through other means, including an executive order directing agencies to prefer institutions with lower indirect cost rates in funding decisions.

Translation: it is not a cap anymore. It is a rigged race.

Follow the money: austerity creates a private market

When you squeeze public research, you do not create efficiency. You create vacancies, shutdowns, and delays. Then you create demand for private substitutes: contract research organizations, private data brokers, proprietary biobanks, vendor lock-in for equipment and cloud compute, and consultants billing by the hour to “streamline compliance” after you fired the compliance staff.

The quiet part: they want scientists who behave like contractors. Deliverables. Deadlines. No dissent. No inconvenient conclusions.

So yes, dropping the NIH overhead cap fight is a win for the institutions that sued and for courts that still use the word “unlawful” like it means something. But do not confuse a lost case with a lost agenda.